You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 110 No. 1, July 1962 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (52)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Skin Vascular Alterations in Diabetes Mellitus

MILTON B. HANDELSMAN, M.D.; THOMAS G. MORRIONE, M.D.; BERNARD GHITMAN, M.D.

Arch Intern Med. 1962;110(1):70-77.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Many studies employing a variety of physiological techniques have demonstrated impaired responses on the part of the superficial smaller blood vessels of diabetics who had no evidences of large vessel disease. In 1930, Starr1 performed "wheal tests" with histamine injected intracutaneously in the legs of stabilized diabetics. He found that in 50 diabetic patients without evidence of arteriosclerosis, 8 had markedly diminished and 17 had moderately diminished wheal formation (50% hyporeactive). In another group of 25 diabetic patients who had evidence of generalized arteriosclerosis but with excellent dorsalis pedis pulsations, 11 had markedly diminished and 9 had markedly decreased wheal responses (80% hyporeactors). Starr also noted that hyporeaction occurred but was reversible in patients with acidosis.

In a more recent study, 7 out of 16 diabetics without demonstrable vascular disease showed inadequate temperature elevation of the skin of the toes after the intravenous administration of tolazoline hydrochloride (Priscoline),2 . . . [Full Text PDF of this Article]


Author Affiliations

BROOKLYN

Departments of Medicine and Pathology, Long Island College Hospital and Brooklyn V.A. Hospital, and State University of New York, Downstate Medical Center.


Footnotes

Submitted for publication Aug. 9, 1961.

Read before a meeting of the Clinical Society of New York Diabetes Association on May 25, 1961.

This work was sponsored by the Van Cott Research Fund, and in part by Research Grant No. A 2850 National Institutes of Health, U.S. Public Health Service.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1962 American Medical Association. All Rights Reserved.